Rahul Salvi

Yes. Thanks for the opportunity. I had a question on improvement in volumes, if any, are we seeing because of the GLP-1 launch in the last 40 days. is there any patient volume accretion happening on that front? And which are the tests basically which these patients are choosing? Any insights on that will be helpful.

But as I understand, you will not attribute the FY27 growth even to a slightest extent to patients who are opting for GLP and the doctors prescribing them those tests, right?

Thank you. That is helpful.

I was looking at the investor presentation. So, I don't know whether this question has been asked by the previous participants, but the domestic business grew by 20% YoY in this quarter and IQVIA reported growth is at 9% . So, can you split the growth between modern trade, hospital sales and the actual primary sales which goes through the channels for our understanding?

And modern trade and eCommerce is the same or it's different?

So, that also explains the -1% volume degrowth, which is shown by IQVIA because they are not capturing the modern trade.